<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Previous studies have shown the association between <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> with <z:e sem="disease" ids="C0014544" disease_type="Disease or Syndrome" abbrv="">epilepsy</z:e> but there are no studies addressing the effect of <z:hpo ids='HP_0001250'>seizure</z:hpo> frequency, duration of <z:e sem="disease" ids="C0014544" disease_type="Disease or Syndrome" abbrv="">epilepsy</z:e>, <z:e sem="disease" ids="C0014544" disease_type="Disease or Syndrome" abbrv="">epilepsy</z:e> type and aetiology on the prevalence of these antibodies in well-evaluated refractory <z:e sem="disease" ids="C0014544" disease_type="Disease or Syndrome" abbrv="">epilepsy</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: Anticardiolipin, anti-beta2-<z:chebi fb="2" ids="17089">glycoprotein</z:chebi> I and antinuclear antibody levels were measured in 105 well-evaluated patients with refractory <z:e sem="disease" ids="C0014547" disease_type="Disease or Syndrome" abbrv="">focal epilepsy</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Clinical determinants included the patient history, electroclinical classification and high resolution brain magnetic resonance imaging </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: Patients with <z:hpo ids='HP_0001250'>seizures</z:hpo> during the month prior to sampling (recent <z:hpo ids='HP_0001250'>seizures</z:hpo>) had increased prevalence of immunoglobulin (Ig) G class anticardiolipin antibodies (29%) compared with healthy controls [13%; age-adjusted odds ratio (OR): 3.09, 95% confidence interval (CI): 1.30-7.34] and patients with no recent <z:hpo ids='HP_0001250'>seizures</z:hpo> (11%; age-adjusted OR: 4.00, CI: 0.84-19.02) </plain></SENT>
<SENT sid="4" pm="."><plain>The patients with recent <z:hpo ids='HP_0001250'>seizures</z:hpo> had increased prevalence of moderate positive IgG class anticardiolipin antibodies (12%) compared with the controls (4%) and the patients with no recent <z:hpo ids='HP_0001250'>seizures</z:hpo> (0%; age-adjusted OR: 4.45, CI: 1.14-17.36) </plain></SENT>
<SENT sid="5" pm="."><plain>The prevalence of IgG class anticardiolipin antibodies was not associated with <z:e sem="disease" ids="C0014544" disease_type="Disease or Syndrome" abbrv="">epilepsy</z:e> type, duration or aetiology </plain></SENT>
<SENT sid="6" pm="."><plain>CONCLUSION: The presence of <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> is associated with recurrent <z:hpo ids='HP_0001250'>seizures</z:hpo> in patients with refractory <z:e sem="disease" ids="C0014547" disease_type="Disease or Syndrome" abbrv="">focal epilepsy</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>The measurement of these antibodies may be useful in evaluating the outcome of <z:e sem="disease" ids="C0014544" disease_type="Disease or Syndrome" abbrv="">epilepsy</z:e> </plain></SENT>
</text></document>